Hunan Camille Biotechnology Co., Ltd. is a professional technology company engaged in the research, development, and production of active pharmaceutical ingredients (APIs) and intermediates. The company was established by a team of senior engineers and engineers with extensive experience in the chemical and pharmaceutical industries. It is dedicated to the research, development, production, and sales of APIs, pharmaceutical intermediates, and fine chemicals, as well as import and export business in related fields. The company's registered office is located in Changsha, Hunan Province, with a well-equipped R&D laboratory in Changsha and a pilot-scale and ton-level production base in Yueyang, Hunan. It has established cooperative relationships with several well-known domestic pharmaceutical companies and can efficiently complete the preparation of products from gram to ton scale. The company has rich R&D and production experience in antitumor drugs, antipsychotic drugs, carbapenems (penems), steroid drugs, and pharmaceutical intermediates, with product technology and quality being highly competitive in the industry. Hunan Camille Biotechnology Co., Ltd. always adheres to the principles of誠信經(jīng)營 (integrity in business) and mutual benefit, winning the trust and long-term cooperation of customers, and achieving sustained and rapid development. Its main products include temozolomide and its intermediate AICA, meropenem and its intermediates, ertapenem and its intermediates, biapenem and its intermediates, among others. The annual production capacity for AICA is 3 tons, for temozolomide 3-5 tons; the annual production capacity for biapenem is 1-2 tons; and the monthly production capacity for meropenem side chain is 3-5 tons.